Autopsy report · NCT04801225

Early Feasibility Study of the Nervive VitalFlow Stimulation for Acute Ischemic Stroke Patients

“Company assets sold. NIH NINDS Grant discontinued.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Nervive, Inc.

Sponsor type

Industry

Conditions

Acute Stroke

Interventions

Non-invasive electromagnetic stimulation for acute stroke treatment

Participants

0

Sites

2

Countries

United States

Trials that died the same way

• Feasibility Testing an Exercise Program to Improve Cognition for T2DM Patients
  “The NIH Grant was terminated” (68% match in meaning)
• Game-Based Intervention to Reduce Alcohol-Related Harms Among Sexual and Gender Minority Youth
  “Grant was terminated by NIH.” (66% match in meaning)
• Developing a Childhood Asthma Risk Passive Digital Marker
  “NIH funding was terminated due to new agency priorities.” (63% match in meaning)
• Safety Study of Nebivolol for COPD Patients
  “Funding was discontinued.” (61% match in meaning)
• Evaluating the Effectiveness of Hybrid and Traditional Speech Therapy for /ɹ/ and /s/ Sound Production
  “Funding discontinued” (58% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.